These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33792733)

  • 1. Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer.
    Gan T; Schaberg KB; He D; Mansour A; Kapoor H; Wang C; Evers BM; Bocklage TJ
    JAMA Netw Open; 2021 Apr; 4(4):e213897. PubMed ID: 33792733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Budding as a Prognostic Marker in Primary Colon Cancer - A Single Center Experience.
    Dukoska DB; Zdravkovski P; Kostadinova-Kunovska S; Krsteska B; Karagjozov P; Dzambaz D; Nikolovski A; Antovic S; Jankulovski N; Petrushevska G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2024 Jun; 45(2):47-58. PubMed ID: 39008643
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
    Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
    World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
    Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
    Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer.
    Giordano PG; Díaz Zelaya AG; Aguilera Molina YY; Taboada Mostajo NO; Ajete Ramos Y; Ortega García R; Peralta de Michelis E; Meneu Díaz JC
    Med Clin (Barc); 2024 Aug; 163(4):159-166. PubMed ID: 38697893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
    Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
    Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
    Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
    Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Radial Margin Positivity With Colon Cancer.
    Amri R; Bordeianou LG; Sylla P; Berger DL
    JAMA Surg; 2015 Sep; 150(9):890-8. PubMed ID: 26132363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.
    Saito K; Okuyama T; Miyazaki S; Oi H; Mitsui T; Noro T; Takeshita E; Ono Y; Urahashi T; Tajima H; Yoshitomi H
    In Vivo; 2022; 36(4):1820-1828. PubMed ID: 35738585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Glasgow Microenvironment Score as a prognostic tool in colorectal carcinoma.
    Ahuja M; Dwarak A; Mallya V; Mandal S; Tomar R; Khurana N; Lal P; Singh K
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S172-S176. PubMed ID: 37147995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
    Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
    JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer.
    Shivji S; Cyr DP; Pun C; Duan K; Sari A; Tomin R; Ng D; Brar A; Zerhouni S; Kennedy E; Brar M; Swallow CJ; Conner J; Kirsch R
    Am J Surg Pathol; 2022 Oct; 46(10):1340-1351. PubMed ID: 35613045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Composition, Inflammation, and 5-Year Outcomes in Colon Cancer.
    Fleming CA; O'Connell EP; Kavanagh RG; O'Leary DP; Twomey M; Corrigan MA; Wang JH; Maher MM; O'Connor OJ; Redmond HP
    JAMA Netw Open; 2021 Aug; 4(8):e2115274. PubMed ID: 34459908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations.
    Unal Kocabey D; Cakir IE
    Ann Diagn Pathol; 2024 Dec; 73():152375. PubMed ID: 39312865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.
    Sinicrope FA; Foster NR; Yoon HH; Smyrk TC; Kim GP; Allegra CJ; Yothers G; Nikcevich DA; Sargent DJ
    J Clin Oncol; 2012 Feb; 30(4):406-12. PubMed ID: 22203756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
    Pihlmann Kristensen M; Korsgaard U; Timm S; Hansen TF; Zlobec I; Hager H; Kjær-Frifeldt S
    Hum Pathol; 2024 Apr; 146():15-22. PubMed ID: 38428823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.